Heparan sulfate facilitates rift valley fever virus entry into the cell

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13767-13771

  de Boer, S M ^a   Kortekaas, J ^b   de Haan, C A M ^a   Rottier, P J M ^a   Moormann, R J M ^a,b   Bosch, B J ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HEPARIN LYASE;

ANIMAL CELL; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL SURFACE; CONTROLLED STUDY; ENZYME MECHANISM; FEMALE; HAMSTER; INFECTION SENSITIVITY; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS VIRULENCE;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HEPARITIN SULFATE; MEMBRANE FUSION; RIFT VALLEY FEVER VIRUS; VIRAL TROPISM;

ANIMALIA; ARTHROPODA; RIFT VALLEY FEVER VIRUS;

EID: 84870704400     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01364-12     Document Type: Article

References (42)

1. Baeuerle PA, Huttner WB. 1986. Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141:870-877.
2. Bird BH, et al. 2008. Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J. Virol. 82:11152-11166.
3. Cardin AD, Weintraub HJ. 1989. Molecular modeling of proteinglycosaminoglycan interactions. Arteriosclerosis 9:21-32.
4. Carroll SA, et al. 2011. Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J. Virol. 85:6162- 6167.
5. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005.Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
6. Chang A, Masante C, Buchholz UJ, Dutch RE. 2012. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J. Virol.86:3230-3243.
7. Chen Y, et al. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
8. de Haan CA, et al. 2005. Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J.Virol.79:14451-14456.
9. Deutscher SL, Nuwayhid N, Stanley P, Briles EI, Hirschberg CB. 1984. Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell 39:295-299.
10. Esko JD, Stewart TE, Taylor WH. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 82:3197-3201.
11. Evans A, et al. 2008. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol. Infect. 136:1261-1269.
12. Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ.2008. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J. Virol. 82:10341-10348.
13. Gandhi NS, Mancera RL. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72:455- 482.
14. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER.1998. β Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 95:7074-7079.
15. Gerrard SR, Bird BH, Albarino CG, Nichol ST. 2007. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 359:459-465.
16. Gottlieb C, Skinner AM, Kornfeld S. 1974. Isolation of a clone of Chinese hamster ovary cells deficient in plant lectin-binding sites. Proc. Natl. Acad.Sci. U.S.A. 71:1078-1082.
17. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. 1998. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156-167.
18. House JA, Turell MJ, Mebus CA. 1992. Rift Valley fever: present status and risk to the Western Hemisphere. Ann. N. Y. Acad. Sci. 653:233-242.
19. Huiskonen JT, Overby AK, Weber F, Grunewald K. 2009. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus:evidence for GN-GC glycoprotein heterodimers. J. Virol. 83:3762-3769.
20. Hulst MM, van Gennip HG, Moormann RJ. 2000. Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns). J. Virol. 74:9553-9561.
21. Kakach LT, Wasmoen TL, Collett MS. 1988. Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J. Virol. 62:826-833.
22. Kao FT, Puck TT. 1967. Genetics of somatic mammalian cells. IV. Properties of Chinese hamster cell mutants with respect to the requirement for proline. Genetics 55:513-524.
23. Kjellén L, Lindahl U. 1991. Proteoglycans: structures and interactions.Annu. Rev. Biochem. 60:443- 475.
24. Klimstra WB, Ryman KD, Johnston RE. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
25. Kortekaas J, et al. 2011. Creation of a nonspreading Rift Valley fever virus. J. Virol. 85:12622-12630.
26. Lehmann F, Tiralongo E, Tiralongo J. 2006. Sialic acid-specific lectins: occurrence, specificity and function. Cell. Mol. Life Sci. 63:1331-1354.
27. Lidholt K, et al. 1992. A single mutation affects both Nacetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis.Proc. Natl. Acad. Sci. U.S.A. 89:2267-2271.
28. Liu J, Thorp SC. 2002. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22:1-25.
29. Lozach PY, et al. 2011. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10:75- 88.
30. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis.Annu. Rev. Biochem. 79:803-833.
31. Mundel B, Gear J. 1951. Rift valley fever; I. The occurrence of human cases in Johannesburg. S. Afr. Med. J. 25:797-800.
32. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. 2010. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 41:61. doi:10.1051/vetres/2010033.
33. Puig-Kröger A, et al. 2004. Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. J. Biol. Chem. 279:25680-25688.
34. Raman S, Hsu TH, Ashley SL, Spindler KR. 2009. Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1. J. Virol. 83:2831-2838.
35. Safaiyan F, et al. 1999. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 274:36267-36273.
36. Schmaljohn CS, Nichol ST. 2007. Bunyaviridae, p 1741-1789. In Knipe DM, et al (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
37. Schowalter RM, Pastrana DV, Buck CB. 2011. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 7:e1002161. doi:10.1371/journal.ppat.1002161.
38. Stanley P, Caillibot V, Siminovitch L. 1975. Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. Cell 6:121-128.
39. Struthers JK, Swanepoel R, Shepherd SP. 1984. Protein synthesis in Rift Valley fever virus-infected cells. Virology 134:118-124.
40. Varki A. 2007. Glycan-based interactions involving vertebrate sialic-acidrecognizing proteins. Nature 446:1023-1029.
41. Won S, Ikegami T, Peters CJ, Makino S. 2006. NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J. Virol. 80:8274-8278.
42. Xiao X, Feng Y, Zhu Z, Dimitrov DS. 2011. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411:253-258.